DJIA 18,071.11 -132.26 -0.73%
NASDAQ 4,965.17 -14.73 -0.30%
S&P 500 2,095.46 -12.32 -0.58%
market minute promo

Pfizer (NYSE: PFE)

34.68 0.12 (0.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $34.71 0.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.49
Previous Close $34.56
Daily Range $34.26 - $34.77
52-Week Range $27.51 - $34.97
Market Cap $212.5B
P/E Ratio 24.51
Dividend (Yield) $1.12 (3.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,626,722
Average Daily Volume 31,785,499
Current FY EPS $2.07




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary Rss Feed

3 Companies That Could Unlock Shareholder Value Through a Split or Spinoff

Motley Fool experts think these companies have a lot of value that could be unlocked if they broke up.

Merck KGaA's Q4 Net Income Flat Y/Y, Provides 2015 Outlook - Analyst Blog

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Pfizer's (PFE) CEO Ian Read Presents at Cowen and Company 35th Annual Healthcare Conference (Transcr

Pfizer's (PFE) CEO Ian Read Presents at Cowen and Company 35th Annual Healthcare Conference (Transcript)

Bristol-Myers Squibb’s $1.6 Billion On New Drug Deals Is Well Spent

Novartis Goes A Step Forward In Treating Lung Cancer

Merck’s Partnership With NGM Is A Bold Move

3 Stocks Moving The Drugs Industry Upward

How and Where to Invest to Outmaneuver the Risks of Disinflation

Lower GDP Estimate Weighs on U.S. Indexes

See More PFE News...

PFE's Top Competitors

PFE $34.68 (0.33%)
Current stock: PFE
JNJ $101.59 (-0.73%)
Current stock: JNJ
ROG $78.13 (-0.43%)
Current stock: ROG
GSK $47.89 (0.38%)
Current stock: GSK